451. Long-term Results of Photodynamic Therapy for Choroidal Neovascularization in Japanese Patients With Pathologic Myopia
- Author
-
Kengo Hayashi, Muka Moriyama, Manabu Mochizuki, Noriaki Shimada, Takeshi Yoshida, Jiying Wang, Takashi Tokoro, Kyoko Ohno-Matsui, and Wakako Hayashi
- Subjects
Adult ,Male ,medicine.medical_specialty ,Refractive error ,genetic structures ,medicine.medical_treatment ,Eye disease ,Visual Acuity ,Photodynamic therapy ,Vision disorder ,Young Adult ,Asian People ,medicine ,Humans ,Prospective Studies ,Fluorescein Angiography ,Young adult ,Prospective cohort study ,Aged ,Aged, 80 and over ,Photosensitizing Agents ,medicine.diagnostic_test ,business.industry ,Middle Aged ,Prognosis ,medicine.disease ,Fluorescein angiography ,Choroidal Neovascularization ,eye diseases ,Surgery ,Ophthalmology ,Choroidal neovascularization ,Photochemotherapy ,Myopia, Degenerative ,Female ,sense organs ,medicine.symptom ,business ,Follow-Up Studies - Abstract
Objective To determine the results of photodynamic therapy (PDT) in highly myopic eyes with choroidal neovascularization (CNV). Design Open-label, consecutive, interventional case series. Methods Forty-eight eyes of 46 consecutive Japanese patients with a myopic CNV were studied. The eyes were treated with PDT and were followed up from 1 to 4 years. The best-corrected visual acuities (BCVAs) at the baseline and after the PDT were compared. Multivariate regression analyses were used to determine the factors that were significantly associated with the BCVA at 3 or 4 years. Results The mean follow-up period was 3.2 years. Sixty-nine percent of the patients obtained angiographic closure by a single PDT treatment, and the average number of PDT treatments was 1.4. Chorioretinal atrophy developed in 61% of the eyes at 3 years and in 70% of the eyes at 4 years. The BCVA did not change significantly after the PDT. Multivariate regression analyses showed that the BCVA at 3 years was significantly correlated with the baseline BCVA and area of chorioretinal atrophy. Analyses of the 20 patients at 4 years or more showed that in 5 of 7 (71.4%) patients with juxtafoveal CNV, chorioretinal atrophy did not develop and that all had BCVA of 0.5 or better. However, in 12 of the 13 patients with a subfoveal CNV, chorioretinal atrophy developed at 4 years, and 10 of these patients had BCVA of 0.1 or worse. Conclusions In highly myopic patients, 69% obtained angiographic closure by a single PDT treatment, and recurrence was rare. These findings indicate that PDT is still a good option for treating CNVs in highly myopic patients.
- Published
- 2011